Silver Moonshots’ Post

The life sciences sector is on the verge of a groundbreaking shift with precision medicine at its core. Our Bench International Technology Team (BITT) Advisory Board Member, Jon Warner, explores this revolution in his latest article, "How Precision Medicine Is Likely to Transform Life Sciences." As we enter an era where treatments are tailored to individual genetic, lifestyle, and environmental factors, the potential for personalized therapies and predictive diagnostics is closer than ever. From genomics and AI to real-time health monitoring, the transformation spans drug discovery, healthcare delivery, and patient empowerment. Discover Jon Warner's insights on the future of life sciences here and how precision medicine could improve patient outcomes, accelerate development, and reshape the healthcare system. 🔗 https://lnkd.in/dRcQh72h What are your thoughts? Do you think precision medicine will become the standard in healthcare, or are there challenges that may limit its reach? Drop a comment below – we’d love to hear your perspective! #PrecisionMedicine #LifeSciences #Innovation #BITT #HealthcareRevolution #PersonalizedTherapies #AI #Genomics #FutureofHealthcare #ExecutiveSearch #Leadership #HealthTech #MedTech #DiversityinPharma #Healthcare #Pharmaceuticals #HealthMonitoring #PatientCare

Demonstrating Scalable Integration of Clinical, Translational, and Manufacturing Data to Explore Role of Manufacturing Approach in Driving Health Outcomes #OHDSISocialShowcase #JoinTheJourney Lead: Ben Smith Team: Trent Peterson, Jessica Manzyuk Background: Interest is growing among cell therapy researchers to better understand relationships between manufacturing approaches and patient outcomes. In the past large multi-site research has been difficult to execute due to the significant effort required in linking clinical and manufacturing data sources. Collaborative observational research has benefitted from growing adoption of the Fast Healthcare Interoperability Resources (FHIR) data standard and the Observational Medical Outcomes Partnership (#OMOP) common data model. Efforts to bridge FHIR and OMOP are also simplifying the automation of data acquisition and integration. With the goal of extending similar benefits to research involving cell therapy manufacturing, we decided to explore the feasibility of using OMOP for integrated clinical and manufacturing datasets. Historically, when researchers seek to integrate new types of data within OMOP CDM, an extension to the model is required to accommodate new concepts. Our approach uses only existing OMOP structure, though custom concepts will need to be added for manufacturing variables not yet used by the OHDSI community. https://lnkd.in/eqPKMEDm

Synkriom, 2024 Global Life Sciences Outlook In 2024, the life sciences sector faces a transformative year marked by advancements in genomics, personalized medicine, and AI driven drug discovery. Emerging technologies are revolutionizing how diseases are diagnosed and treated, with a growing emphasis on precision health. Sustainability and ethical considerations are increasingly influencing research and development practices. Collaboration between academia, industry, and regulatory bodies is crucial for navigating complex challenges and accelerating innovation. Global health disparities remain a significant concern, driving efforts to improve accessibility and equity in healthcare. Investment in digital health solutions continues to rise, promising enhanced patient outcomes and streamlined healthcare delivery. 👉 Connect with us: https://bit.ly/3W0YNbZ 📩 contact@synkriom.com #Synkriom #healthcare #medicine #lifesciences #Clinicaltrails #healthtech #drugdiscovery #lifesciencetrends #MedicalTechnology #teamsynkriom #biotechnology #patientcare #machinelearning #digitalteam #drugdevelopment #automation #digitalhealthsolutions #digitalhealth #usa #ai

Precision Medicine Market Future Outlook and Projections Get your Sample PDF: https://lnkd.in/d-tjg_p3 In today's rapidly evolving healthcare landscape, precision medicine is paving the way for groundbreaking advancements. The #PrecisionMedicineMarket is set to revolutionize how we approach diagnosis, treatment, and prevention, tailoring healthcare solutions to individual genetic profiles, environments, and lifestyles. Key Highlights: 🌟 Personalized Treatment Plans: Say goodbye to one-size-fits-all. Precision medicine focuses on customized care, enhancing treatment efficacy and minimizing side effects. 🌟 Technological Innovations: Cutting-edge technologies like AI, genomics, and big data analytics are driving unprecedented growth in this market. 🌟 Patient-Centric Approach: Empowering patients with personalized health insights and proactive management strategies. 🌟 Collaborative Ecosystem: Pharma companies, tech giants, and healthcare providers are joining forces to push the boundaries of what's possible. The numbers speak volumes: 📈 Market growth is projected to soar, with estimates reaching new heights by 2030. 💡 Investment opportunities abound as stakeholders recognize the transformative potential of precision medicine. #HealthcareInnovation #PersonalizedMedicine #Genomics #HealthcareTechnology #FutureOfMedicine #PrecisionHealth #MedicalBreakthroughs #PatientCare #InvestmentOpportunities

"In a world of endless possibilities, translational precision medicine holds the key to unlocking extraordinary potential. Every day, I'm inspired by the chance to bridge the gap between scientific discovery and life-changing treatments. I believe that by fostering collaboration, embracing innovation, and putting patients at the heart of our work, we can create a future where diseases are not only treated but prevented. Let's harness the power of data, technology, and human ingenuity to redefine healthcare. Are you passionate about making a difference? Let's connect and explore how we can work together to advance translational precision medicine. Your expertise and perspective are invaluable. #translationalprecisionmedicine #healthcareinnovation #biotech #medtech #lifesciences #patientfocused #research #collaboration #hope #futureofhealthcare"

Register here (https://lnkd.in/eCKN6PhH) as we unravel the intersection of science fiction and reality, where thoughts wield power over devices and paralyzed individuals find new voices and mobility through neural prosthetics. But amidst the awe-inspiring breakthroughs lies a labyrinth of ethical dilemmas and societal repercussions. Deepthi Balan An experienced life science strategist focusing on emerging trends, innovative technologies and business opportunities that are driving the future landscape of healthcare, medical devices & diagnostics, pharmaceuticals and personal care industries. Kirti Vashisth A passionate and experienced biotechnologist possessing profound insights into the ever-evolving field of life sciences, MedTech and healthcare, with a keen awareness of emerging trends, disruptive technologies, and inventive methodologies. #NeuralImplants #AssistiveDevices #ArtificialIntelligence #BrainMachineInterfaces #Neurotechnology #MedicalAdvancements

Very insightful few days with diagnostics leaders from the Middle East and Europe. Not without challenges, but looking forward to increasingly leveraging the potential benefits across multiple areas including: 1️⃣ **Personalized Medicine** for tailored treatments based on genetic makeup. 2️⃣ **AI and Machine Learning** for enhanced diagnostic accuracy and efficiency. 3️⃣ **Point-of-Care Testing** for rapid and well-governed on-site diagnostics. 4️⃣ **Wearable Devices** for continuous health tracking and early disease detection. 5️⃣ **Molecular Diagnostics** for more precise, and less invasive, methods with NGS and CRISPR. 6️⃣ **EHR Integration** for improved data sharing and contributions to patient outcomes. 7️⃣ **Regenerative Medicine** for the monitoring of advanced therapies. 8️⃣ **Sustainability** for increasingly cost-effective and environmentally friendly processes and solutions. 9️⃣ **Regulatory Evolution** for assuring patient safety and equitable access. 🔟 **Interdisciplinary Collaboration** for driving innovation across multiple fields. The future increasingly looks bright - now to achieving appropriate adherence, and scale, in order to truly have an impact on better outcomes for all. 🚀 #HealthcareInnovation #LaboratoryDiagnostics #PrecisionMedicine #DigitalHealth

I am a big fan of innovation and leveraging technology to improve and accelerate genomic testing worldwide. But we also need to acknowledge that getting everyone to face the right direction and commit to this is not easy. From lab scientists to decision-makers and data analysts to medical directors, we need to find the right ways to ensure we are all supported in the right way. It is the only way to have a solid collaboration. In my discussion with Véronique Forest from Illumina, we talked about how vital collaboration is for the healthcare industry and the steps we need to take to continue to advance discovery. By working together, we will see better patient outcomes. #ClinicalGenomics #Healthcare #NGS Automata

Proud to share our recent article on how we're using AI to change the game in drug design and development here at Pivot-al-ai ! We’re seeing firsthand how AI is boosting early clinical trial success, optimizing compounds, and speeding up the process to bring more effective, personalized therapies to market. This is what the future of healthcare looks like, and we’re excited to be leading the charge! #ai #drugdesign #drugdevelopment

"🌐💊 Big Tech Meets Biopharma! Get ready for a groundbreaking transformation at #JPM2024, where AI is set to redefine drug discovery! From advanced algorithms to personalized medicine, the future of healthcare is here. #AIinHealthcare #DrugDiscovery 🚀💡"